scispace - formally typeset
I

Italo Faria do Valle

Researcher at Northeastern University

Publications -  38
Citations -  1087

Italo Faria do Valle is an academic researcher from Northeastern University. The author has contributed to research in topics: Network medicine & Medicine. The author has an hindex of 13, co-authored 31 publications receiving 598 citations. Previous affiliations of Italo Faria do Valle include Coordenadoria de Aperfeiçoamento de Pessoal de Nível Superior & Universidade Federal de Minas Gerais.

Papers
More filters
Posted Content

Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19

TL;DR: Three network-based drug repurposing strategies are deployed, relying on network proximity, diffusion, and AI-based metrics, allowing to rank all approved drugs based on their likely efficacy for COVID-19 patients, and aggregate all predictions, to arrive at 81 promising repurpose candidates.
Journal ArticleDOI

Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data

TL;DR: A pipeline that detects a wide range of somatic single nucleotide variants, with good validation rates, from exome sequencing data of cancer samples is presented and the advantage of combining standard algorithms to create the GATK-LODN method, that increased specificity and sensitivity of GatK results is shown.
Journal ArticleDOI

Acceleration of leukocytes' epigenetic age as an early tumor and sex-specific marker of breast and colorectal cancer.

TL;DR: It is shown that the epigenetic age estimated from blood DNA methylation data is statistically significantly associated to future breast and male colorectal cancer development, suggesting that the chance of developing age-related diseases may be predicted by circulating epigenetic markers, with a dependence upon tumor type, sex and age estimator.
Journal ArticleDOI

RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN.

TL;DR: This work showed that RUNX2 transcription in thyroid and breast cancer requires the cooperation of three distantly located enhancers (ENHs) brought together by chromatin three-dimensional looping and identified c-JUN as the principal pivot of this regulatory platform.